Commitment COM-269
Post-approval commitment for SwissMedic-2021-0069. Category: Paediatric Study. Priority: low.
Commitment ID
COM-269
Application
Authority
Swissmedic
Category
Paediatric Study
Priority
low
Status
In Progress
Due Date
2025-03-24
Completed At
—
Owner
Tomoko Ikeda
Created
2023-01-15
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.